Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price Rises 5.25% Today
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Morepen Laboratories Ltd. rose to Rs 109.25, up 5.25% today, taking its market capitalisation to Rs 5,869.13 crore.
Morepen Laboratories Share Price traded at Rs 109.25 on 02 September 2026, up Rs 5.45 or 5.25% from the previous close of Rs 103.8. The stock opened at Rs 104, touched a high of Rs 110, a low of Rs 103.5, and recorded turnover of Rs 7.07 crore. The move is clear in the verified market data, but the supplied dataset does not identify a company-specific catalyst behind today’s rise.
That makes the stock interesting mainly from a market-data perspective. Investors tracking Morepen Laboratories Share Price are likely to focus on three things: whether the stock is holding near the day’s high, how its valuation compares with the Pharmaceuticals & Drugs industry, and whether its profitability metrics justify continued attention.
Morepen Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 109.25 |
| Previous Close | Rs 103.8 |
| Today's Move | Rs 5.45 (+5.25%) |
| Open | Rs 104 |
| High | Rs 110 |
| Low | Rs 103.5 |
| Turnover | Rs 7.07 crore |
| Market Capitalisation | Rs 5,869.13 crore |
| Market Cap Category | Mid Cap |
Morepen Laboratories Ltd. (MOREPENLAB) rose to Rs 109.25 from the previous close of Rs 103.8, a move of Rs 5.45 or 5.25%. The stock opened at Rs 104, reached a high of Rs 110, recorded a low of Rs 103.5.
Morepen Laboratories Share Price rose by Rs 5.45 in today’s session, moving from Rs 103.8 to Rs 109.25. The intraday setup was constructive: the stock opened at Rs 104, briefly traded near Rs 103.5, then climbed to Rs 110. Trading near Rs 109.25 after touching Rs 110 means the stock was holding close to the session high at the time of the article.
The day’s range of Rs 103.5 to Rs 110 shows active participation, while turnover of Rs 7.07 crore indicates meaningful trading interest. On price action alone, the stock clearly stood out in the session. However, price strength by itself does not explain why the move happened, and the available data should not be stretched into an unsupported catalyst narrative.
For readers following Morepen Laboratories Share Price today, the most useful conclusion is simple: the stock posted a strong one-day gain, stayed above the previous close after opening, and retained most of its intraday advance.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,869.13 crore |
| P/E Ratio | 40.47x |
| P/B Ratio | 4.37x |
| ROE | 11.78% |
| ROCE | 15.48% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.19% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 40.47x, P/B 4.37x, ROE 11.78%, ROCE 15.48%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 5869.13 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 40.47x, P/B at 4.37x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 15.48%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 40.47x |
| Benchmark Median P/E | 31.29x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 4.37x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 11.78% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 15.48% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 5,869.13 crore |
| Benchmark Median Market Cap | Rs 720.34 crore |
Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 40.47x, which is above the benchmark median of 31.29x, a difference of +29.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 11.78%, which is below the benchmark median of 11.79%, a difference of -0.08%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 15.48%, which is above the benchmark median of 13.63%, a difference of +13.57%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,69,309.92 | 38.29 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,425.7 | 83.18 | 13.77 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,347.12 | 86.48 | 21.02 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,919.92 | 25.73 | 4.31 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,392.76 | 33.99 | 3.26 | 11.83 | 16 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 40.47x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.48% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 5,869.13 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- The stock rose 5.25% to Rs 109.25 from Rs 103.80.
- It traded in a Rs 103.50 to Rs 110 range and held near the high.
- Turnover stood at Rs 7.07 crore.
- P/E of 40.47 and P/B of 4.37 keep valuation in focus.
- ROE of 11.78% and ROCE of 15.48% provide profitability context.
About Morepen Laboratories
Morepen Laboratories Ltd. is a listed Indian company in Healthcare under Pharmaceuticals & Drugs. Based on the supplied dataset, the company is being evaluated here through price action, valuation, profitability, and peer benchmarks rather than any reported corporate event. Within a same-industry universe of 201 companies, it sits above the median market-cap level but well below India’s biggest pharma companies.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can follow Morepen Laboratories Share Price on the Morepen Laboratories Ltd. (MOREPENLAB) live share-price page. You can also use the Univest top gainers screener and Univest market blogs for broader market context, peer views, and daily stock updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Morepen Laboratories Share Price rising today?
Ans. Morepen Laboratories Share Price was up 5.25% at Rs 109.25 versus the previous close of Rs 103.80. The supplied data confirms the rise, but it does not establish a company-specific catalyst.
What is Morepen Laboratories Share Price today?
Ans. Morepen Laboratories Share Price was Rs 109.25 at the time of the article. The stock opened at Rs 104, traded between Rs 103.50 and Rs 110, and was up Rs 5.45 on the day.
How does Morepen Laboratories compare with its industry on valuation and returns?
Ans. The company’s P/E of 40.47 is above the industry median of 31.29 but below the industry average of 48.12. Its P/B of 4.37 is above the industry median of 2.88 and close to the average of 4.35. ROE of 11.78%.
What is the market capitalisation of Morepen Laboratories?
Ans. Morepen Laboratories had a market capitalisation of Rs 5,869.13 crore. That is above the same-industry median market cap of Rs 720.34 crore, but below the industry average of Rs 14,208.71 crore.
